Search Results - "Meeker, A.K."

Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance by Martin, A M, Nirschl, T R, Nirschl, C J, Francica, B J, Kochel, C M, van Bokhoven, A, Meeker, A K, Lucia, M S, Anders, R A, DeMarzo, A M, Drake, C G

“…BACKGROUND: Primary prostate cancers are infiltrated with programmed death-1 (PD-1) expressing CD8+ T-cells. However, in early clinical trials, men with…”
Get full text

Prostatic preneoplasia and beyond by Joshua, A.M., Evans, A., Van der Kwast, T., Zielenska, M., Meeker, A.K., Chinnaiyan, A., Squire, J.A.

“…Prostate cancer is a heterogeneous neoplasm both with regard to its development, molecular abnormalities and clinical course. For example, in the United…”
Get full text

TERT PROMOTER MUTATIONS OCCUR FREQUENTLY IN GLIOMAS AND A SUBSET OF TUMORS DERIVED FROM CELLS WITH LOW RATES OF SELF-RENEWAL by Yan, H., Killela, P. J., Reitman, Z. J., Jiao, Y., Bettegowda, C., Agrawal, N., Diaz, L. A., Friedman, A. H., Friedman, H., Gallia, G. L., Giovanella, B. C., Grollman, A. P., He, T. C., He, Y., Hruban, R. H., Jallo, G. I., Mandahl, N., Meeker, A. K., Mertens, F., Netto, G. J., Rasheed, B. A., Riggins, G. J., Rosenquist, T. A., Schiffman, M., Shih, I., Theodorescu, D., Torbenson, M. S., Velculescu, V. E., Wang, T. L., Wentzensen, N., Wood, L. D., Zhang, M., Healy, P., Yang, R., Diplas, B., Wang, Z. H., Greer, P., Zhu, H. S., Wang, C., Carpenter, A., Herndon, J. E., McLendon, R. E., Kinzler, K. W., Vogelstein, B., Papadopoulos, N., Bigner, D. D.

“…BACKGROUND: Malignant cells must maintain their telomeres, but genetic mechanisms responsible for telomere maintenance in tumors have only recently been…”
Get full text